These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 10073448)

  • 1. Value of patch tests in pristinamycin-induced drug eruptions.
    Mayence C; Dompmartin A; Verneuil L; Michel M; Leroy D
    Contact Dermatitis; 1999 Mar; 40(3):161-2. PubMed ID: 10073448
    [No Abstract]   [Full Text] [Related]  

  • 2. Eczematous-like drug eruption induced by synergistins.
    Michel M; Dompmartin A; Szczurko C; Castel B; Moreau A; Leroy D
    Contact Dermatitis; 1996 Feb; 34(2):86-7. PubMed ID: 8681563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug skin tests in cutaneous adverse drug reactions to pristinamycin: 29 cases with a study of cross-reactions between synergistins.
    Barbaud A; Trechot P; Weber-Muller F; Ulrich G; Commun N; Schmutz JL
    Contact Dermatitis; 2004 Jan; 50(1):22-6. PubMed ID: 15059099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Contact dermatitis caused by pristinamycin after sensitization to topical virginiamycin].
    Pillette M; Claudel JP; Muller C; Lorette G
    Allerg Immunol (Paris); 1990 May; 22(5):197. PubMed ID: 2142889
    [No Abstract]   [Full Text] [Related]  

  • 5. Patch testing for evaluating drug reactions due to systemic antibiotics.
    Cham PM; Warshaw EM
    Dermatitis; 2007 Jun; 18(2):63-77. PubMed ID: 17498411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Toxidermatitis after oral pristinamycin].
    Bernard P; Fayol J; Bonnafoux A; Bedane C; Delrous JL; Catanzano G; Bonnetblanc JM
    Ann Dermatol Venereol; 1988; 115(1):63-6. PubMed ID: 2967042
    [No Abstract]   [Full Text] [Related]  

  • 7. Allergic contact dermatitis to virginiamycin. False cross-sensitivity with pristinamycin.
    Baes H
    Dermatologica; 1974; 149(4):231-5. PubMed ID: 4617690
    [No Abstract]   [Full Text] [Related]  

  • 8. Polysensitivity in delayed cutaneous adverse drug reactions to macrolides, clindamycin and pristinamycin: clinical history and patch testing.
    El Khoury M; Assier H; Gener G; Paul M; Haddad C; Chosidow O; Wolkenstein P; Ingen-Housz-Oro S
    Br J Dermatol; 2018 Oct; 179(4):978-979. PubMed ID: 29747236
    [No Abstract]   [Full Text] [Related]  

  • 9. Cutaneous reaction to oral spironolactone with positive patch test.
    Alonso JC; Ortega FJ; Gonzalo MJ; Palla PS
    Contact Dermatitis; 2002 Sep; 47(3):178-9. PubMed ID: 12537001
    [No Abstract]   [Full Text] [Related]  

  • 10. The potential utility of patch testing in identifying the causative agent of morbilliform drug eruptions.
    Endo JO; Davis C; Powell DL
    Dermatitis; 2011; 22(2):114-5. PubMed ID: 21504698
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pseudomembranous colitis after pristinamycin].
    Gavazzi G; Barnoud R; Lamloum M; Coumé M; Fillipi M; Debray M; Couturier P; Franco A
    Rev Med Interne; 2001 Jul; 22(7):672-3. PubMed ID: 11508164
    [No Abstract]   [Full Text] [Related]  

  • 12. Occupational airborne contact dermatitis from pristinamycin.
    Blancas-Espinosa R; Conde-Salazar L; Pérez-Hortet C
    Contact Dermatitis; 2006 Jan; 54(1):63-5. PubMed ID: 16426300
    [No Abstract]   [Full Text] [Related]  

  • 13. Contact dermatitis from 3 different allergens in Solaraze gel.
    Kleyn CE; Bharati A; King CM
    Contact Dermatitis; 2004 Oct; 51(4):215-6. PubMed ID: 15500677
    [No Abstract]   [Full Text] [Related]  

  • 14. Delayed reaction to oral treatment with clindamycin.
    Vicente J; Fontela JL
    Contact Dermatitis; 1999 Oct; 41(4):221. PubMed ID: 10515103
    [No Abstract]   [Full Text] [Related]  

  • 15. Delayed-type allergy to oral nimodipine.
    Nucera E; Schavino D; Roncallo C; de Pasquale T; Buonomo A; Pollastrini E; Patriarca G
    Contact Dermatitis; 2002 Oct; 47(4):246-7. PubMed ID: 12492537
    [No Abstract]   [Full Text] [Related]  

  • 16. An isotopic response to patch testing.
    Bell HK; King CM
    Contact Dermatitis; 2003 Sep; 49(3):171-2. PubMed ID: 14678227
    [No Abstract]   [Full Text] [Related]  

  • 17. Spiramycin-related cutaneous eruption confirmed by patch testing.
    Poveda-Montoyo I; Álvarez-Chinchilla PJ; García Del Pozo MC; Encabo B; Silvestre JF
    Contact Dermatitis; 2018 Mar; 78(3):233-234. PubMed ID: 29430709
    [No Abstract]   [Full Text] [Related]  

  • 18. [A rare sensitization: that due to staphylomycin].
    Castelain PY
    Bull Soc Fr Dermatol Syphiligr; 1971; 78(5):526-7. PubMed ID: 4262120
    [No Abstract]   [Full Text] [Related]  

  • 19. [Baboon syndrome].
    Oehler E; Eftekari-Hassanlouie S; Le Guern A
    Rev Prat; 2014 Dec; 64(10):1348. PubMed ID: 25665308
    [No Abstract]   [Full Text] [Related]  

  • 20. FDE to macrolides.
    San Pedro de Saenz B; Gómez A; Quiralte J; Florido JF; Martín E; Hinojosa B
    Allergy; 2002 Jan; 57(1):55-6. PubMed ID: 11991294
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.